Guinea-Bissau vs Suriname: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Guinea-Bissau
68.0%
in 2024
Suriname
69.0%
in 2024
Guinea-Bissau rank
172nd
Suriname rank
170th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Guinea-Bissau
- Suriname
How they compare
Suriname currently reports 69.0% against 68.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 4 times across 16 shared years of data; in 2009 it was Suriname ahead.
Guinea-Bissau ranks 172nd and Suriname ranks 170th of 192 countries.
Across the 3 decades both report, Guinea-Bissau averaged higher in 2 and Suriname in 1.
Head to head by decade
| Decade | Guinea-Bissau | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.0% | 87.0% | 7.0% | Suriname |
| 2010s | 84.5% | 76.2% | 8.3% | Guinea-Bissau |
| 2020s | 71.4% | 68.2% | 3.2% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Guinea-Bissau or Suriname?
- Suriname, at 69.0% against 68.0% in Guinea-Bissau as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Guinea-Bissau and Suriname?
- 1.0%, with Suriname ahead.
- How many years of comparable data are there for Guinea-Bissau and Suriname?
- 16 years are reported by both, from 2009 to 2024.
- How do Guinea-Bissau and Suriname rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Guinea-Bissau ranks 172nd and Suriname ranks 170th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.